Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate The Beauty Health Company before investing.

In this article, we go over a few key elements for understanding The Beauty Health Company’s stock price such as:

• The Beauty Health Company’s current stock price and volume
• Why The Beauty Health Company’s stock price changed recently
• Upgrades and downgrades for SKIN from analysts
• SKIN’s stock price momentum as measured by its relative strength

About The Beauty Health Company (SKIN)

Before we jump into The Beauty Health Company’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

The Beauty Health Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells esthetic technologies and products in the Americas, the Asia-Pacific, Europe, the Middle East, and Africa. The company’s flagship product is HydraFacial, which enhances the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. It also offers Syndeo devices, which are delivery systems that are designed to connect providers to the consumer’s preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling and nanoneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive peptide solutions and take home sprays for treating scalp health. In addition, it operates the MyBeautyHealth mobile application for consumers to earn loyalty points and unlock savings, log skin concerns and receive personalized treatment plans, and find and connect with Hydrafacial providers. The Beauty Health Company was founded in 1997 and is headquartered in Long Beach, California.

Want to learn more about The Beauty Health Company’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about The Beauty Health Company.

The Beauty Health Company’s Stock Price as of Market Close

As of November 28, 2025, 12:59 PM, CST, The Beauty Health Company’s stock price was $1.480.

The Beauty Health Company is up 2.07% from its previous closing price of $1.450.

During the last market session, The Beauty Health Company’s stock traded between $1.410 and $1.500. Currently, there are approximately 126.89 million shares outstanding for The Beauty Health Company.

The Beauty Health Company’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

The Beauty Health Company Stock Price History

The Beauty Health Company’s (SKIN) price is currently up 3.5% so far this month.

During the month of November, The Beauty Health Company’s stock price has reached a high of $1.740 and a low of $1.235.

Over the last year, The Beauty Health Company has hit prices as high as $2.690 and as low as $0.780. Year to date, The Beauty Health Company’s stock is down 6.92%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused The Beauty Health Company Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of November 28, 2025, there was 1 analyst who downgraded The Beauty Health Company’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate The Beauty Health Company’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on The Beauty Health Company’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

The Beauty Health Company’s current valuation based on AAII’s Value Grade is a C, which means it is considered to be Average.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about The Beauty Health Company (SKIN) by visiting AAII Stock Evaluator.

Relative Price Strength of The Beauty Health Company

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of November 28, 2025, The Beauty Health Company has a weighted four-quarter relative price strength of -6.34%, which translates to a Momentum Score of 37 and is considered to be Weak.

Want to learn more about how The Beauty Health Company is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

The Beauty Health Company Stock Price: Bottom Line

As of November 28, 2025, The Beauty Health Company’s stock price is $1.480, which is up 2.07% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like The Beauty Health Company stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.